Molecular mechanisms of lipopolysaccharide induced ICAM-1 expression in A549 cells

Inflamm Res. 2000 Feb;49(2):63-72. doi: 10.1007/s000110050560.

Abstract

Objective and design: Lung intercellular adhesion molecule-1 (ICAM-1) expression is increased by LPS or hyperoxia on type II cells in vivo. The goals of the present study were to determine the mechanisms of ICAM-1 expression in a lung alveolar epithelial cell line (A549) exposed to lipopolysaccharide (LPS).

Materials: A549 cells, a transformed human cell line with characteristics of alveolar epithelial cells, were used.

Treatment: Cells were exposed to LPS, TNF-alpha, IL-1beta, or media alone for up to 12 h.

Methods: Northern blot analyses were done to determine mRNA expression of ICAM-1 after exposures. Protein binding to NF-kappaB sequences were determined by gel mobility shift assays and super-shift analysis.

Results: ICAM-1 mRNA expression was induced in A549 cells with exposure to LPS for 1 to 4 h, and was diminished to baseline at 8 h, and the inductions were independent of TNF-alpha and IL-1beta expression. Nuclear protein extracts from LPS-exposed cells bound to a NF-kappaB sequence and the timing of increased binding correlated closely with ICAM-1 mRNA induction. Super-shift studies indicated that p65 was involved in the binding to the NF-kappaB sequence and p50 was not.

Conclusion: LPS inducibility of ICAM-1 mRNA in A549 cells is independent of TNF- and IL-1 in A549 cells, and the similar time course of mRNA induction and NF-kappaB activation suggest the induction of ICAM-1 is mediated, in part, by NF-kappaB.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Binding Sites
  • Blotting, Northern
  • Cell Line, Transformed
  • Epithelial Cells / metabolism
  • Gene Expression / drug effects*
  • Humans
  • Intercellular Adhesion Molecule-1 / genetics*
  • Interleukin-1 / pharmacology
  • Lipopolysaccharides / pharmacology*
  • NF-kappa B / metabolism
  • Pulmonary Alveoli / metabolism*
  • RNA, Messenger / biosynthesis
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Interleukin-1
  • Lipopolysaccharides
  • NF-kappa B
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Intercellular Adhesion Molecule-1